There it is - never seen a better 4c commentary. Blown away!
Orphan drugs, multi-billion dollar markets, market gaps through onset mismatches, appropriate device chosen, Camargo on the scene, licences being applied for, cash in the bank, all star executive team.
Even the white label is picking up interest.
The turnaround has clearly started and the the ugly duckling still can't catch a bid.
Market has misjudged this one.
Imo
Ann: Quarterly Activities Report, page-2
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.744M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500099 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 24000 | 1 |
View Market Depth
| Last trade - 16.12pm 28/06/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable